Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) BCG Vaccine Market 2017 Forecast to 2022

SKU ID : GIR- 10695703

Publishing Date : 21-Nov-2017

No. of pages : 120

PRICE
4880
9760

  • BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

    Scope of the Report:
    This report focuses on the BCG Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    Merck
    Sanofi Pasteur
    Japan BCG Lab
    China National Biotec
    Serum Institute of India
    Intervax
    GSBPL

    Market Segment by Regions, regional analysis covers
    North America (USA, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Columbia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Immune BCG
    Therapy BCG

    Market Segment by Applications, can be divided into
    Hospitals
    Clinics
    Others

    There are 15 Chapters to deeply display the global BCG Vaccine market.

    Chapter 1, to describe BCG Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the top manufacturers of BCG Vaccine, with sales, revenue, and price of BCG Vaccine, in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the global market by regions, with sales, revenue and market share of BCG Vaccine, for each region, from 2012 to 2017;

    Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

    Chapter 12, BCG Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

    Chapter 13, 14 and 15, to describe BCG Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports